Outpatient Clinics

Assessment and management of people with history of adverse events or identified risks of serious adverse events to immunisations including COVID-19 immunisations; assessment and management of people with a history of adverse events to antibiotics, particularly those with severe reactions or individuals at high risk for serious infections.

Availability

North South North West Statewide

Scope

• The clinic will provide secondary referral operational services to members of the public aged >12 years at risk of severe reactions to antibiotics or immunisations including COVID-19 immunisations.
• Service will include case management of affected individuals, allergy testing, immunisation and antibiotic challenges and de-labelling allergy alerts where appropriate.
• Clinic appointments will be scheduled face-to-face or via telehealth.
• The clinic does not provide services for the following:
  • history of anaphylaxis to stinging insects (see Jack Jumper Clinic)
  • suspected food or environmental allergies**
  • anaesthetic allergy testing**
  • **These services are available for children in the Paediatrics Clinics. For adults, please see HealthPathways Tasmania for care pathways.

Emergency conditions

This clinic is not for emergency presentations

Referral process

Paediatric referrals in the first instance should be referred to the regional General Paediatrics Clinic. Onward referral to the SIAC will be arranged if required on a case-by-case basis.

Referrals for immunisation including COVID-19 immunisations: Professor Katie Flanagan

Referrals for antibiotic case management: Dr Jennifer O’Hern / Professor Paul Cameron

Please see HealthPathways Tasmania Immunology.

Referrals need sufficient information to allow triage and must conform to the Referral Standards as outlined on the For Clinicians page.

Referrals are registered by the clinic and are triaged according to the specific clinic guidelines.

Referrals are accepted from GPs, Medical Specialists and Public Health Clinicians.

Clinic appointments are based on clinical priority.

Anyone who has experienced an Adverse Event Following Immunisation, including COVID-19 immunisation, should first have their adverse event reported to the Communicable Disease Prevention Unit, Department of Health, through Public Health Services (see Reporting Adverse Events Following Immunisation (AEFI)).

Referral template

For use by health professionals only

• Referral template - Medical Director
• Referral template - Best Practice

Additional information

National Centre for Immunisation Research and Surveillance (NCIRS) – NCIRS resources & ATAGI clinical advices

National Centre for Immunisation Research and Surveillance (NCIRS) – COVID-19 vaccination – summary for immunisation providers

Australasian Society of Clinical Immunology and Allergy (ASCIA) - Patients, Consumers, Carer’s information

Australasian Society of Clinic Immunology and Allergy (ASCIA) Guidelines: Acute Management of Anaphylaxis

Brighton Collaboration Anaphylaxis: Case Definition Companion Guide

For more information, please see the Tasmanian HealthPathways website.